Cargando…

Use of ticagrelor and the risks of pneumonia and pneumonia-specific death in patients with non-acute coronary syndrome conditions: a population-based cohort study

Previous studies have shown that ticagrelor reduced risk of pneumonia in patients with acute coronary syndrome (ACS) compared to clopidogrel, however, its effect in patients with non-ACS cardiovascular diseases remains uncertain. The aim was to investigate the effect of ticagrelor on pneumonia and p...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Qi, Tsoi, Man Fung, Fei, Yue, Cheung, Ching Lung, Cheung, Bernard M. Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516893/
https://www.ncbi.nlm.nih.gov/pubmed/34650116
http://dx.doi.org/10.1038/s41598-021-00105-z